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Abstract
Background: In ovarian cancer (OC) cells, Snail was reported to induce the epithelial-to-mesenchymal transition
(EMT), which is a critical step in OC metastasis. At present little is known about controlling Snail expression in OC
cells by using specific microRNAs (miRNAs).
Methods: We first used a computational target prediction analysis to identify 6 candidate miRNAs that bind to
the 3′-untranslated region (3′-UTR) region of the Snail mRNA. Among these miRNAs, two miRNAs (miR-137 and
miR-34a) with a potential to regulate Snail were validated by quantitative real-time PCR, Western blot analysis,
and Snail 3′-UTR reporter assays. We assessed the effects of miR-137 and miR-34a on EMT, invasion and sphere
formation in OC cells. We also evaluated the expression of miR-137 and miR-34a in OC tissues and adjacent normal
tissues and analyzed the relationship between their expression and patient survival.
Results: We report that OC tissues possess significantly decreased levels of miR-137 and miR-34a and increased
expression of Snail when compared to their adjacent normal tissues, and lower miR-137 and miR-34a expression
correlates with worse patient survival. Using luciferase constructs containing the 3′-UTR region of Snail mRNA
combined with miRNA overexpression and mutagenesis, we identified miR-137 and miR-34a as direct suppressors
of Snail in OC cells. The introduction of miR-137 and miR-34a resulted in the suppression of Snail at both the
transcript and protein levels, and effectively suppressed the EMT phenotype and sphere formation of OC cells.
However, the inhibition of miR-137 and miR-34a with antisense oligonucleotides promoted EMT and OC cell
invasion. Moreover, ectopic expression of Snail significantly reversed the inhibitory effects of miR-137 and miR-34a on
OC cell invasion and sphere formation.
Conclusions: These findings suggest that both miR-137 and miR-34a act as Snail suppressors to negatively regulate
EMT, invasive and sphere-forming properties of OC cells.
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Background
The majority (75 %) of patients with ovarian cancer
(OC) present with advanced disease and widely metastatic
disease [1, 2]. In OC, the acquisition of invasiveness is ac-
companied by a shift from epithelial to mesenchymal
phenotype, also called the epithelial-to-mesenchymal tran-
sition (EMT), which endows cancer cells with increased
motility and invasiveness to seed metastasis and with stem
cell-like properties, such as upregulation of stem cell
genes (CD44 and CD133) and self-renewal ability [3, 4].
The EMT process can be initiated by a group of transcrip-
tion factors including SNAIL (Snail), which repress the ex-
pression of epithelial markers (E-cadherin and ZO-1), and
induce the levels of mesenchymal markers (Vimentin and
N-cadherin) [5]. Therefore, identification of key actors
regulating Snail expression and EMT in OC cells would
have tremendous clinical utility.
Growing evidence suggests that a number of epigen-
etic mechanisms control the expression of genes that
facilitate EMT and induce metastasis [6]. For example,
microRNAs (miRNAs) have important roles in the regu-
lation of cancer cell invasion and motility, by suppress-
ing or promoting EMT [7]. In addition, several miRNAs
[8–11] have been implicated in the regulation of Snail
expression in human cancers other than OC. To date,
however, little is known about controlling Snail expres-
sion in OC cells by using specific miRNAs.
In this study, we provide evidence that miR-137 and
miR-34a directly bind to and down-regulate Snail levels
to suppress EMT, invasion and sphere-forming ability of
OC cells, and that the repression of these two miRNAs
is significantly correlated with worse patient survival
in OC.
Methods
Reagents and cell culture
Human OC cell lines (SKOV-3 and ES-2) were ob-
tained from the American Type Culture Collection
(Manassas, VA), and were cultured in DMEM/F12
medium (Invitrogen) supplemented with 10 % fetal
bovine serum (FBS, Invitrogen). Normal ovarian epi-
thelial cells (NOEC, Pricells, Wuhan, China) were cul-
tured in Ham’s F-12 (Gibco) supplemented with 20 %
FBS (Gibco). MiRNA mimic and miRNA inhibitor for miR-
137 or miR-34a (30 nM, Ambion), Snail siRNA (5 nM,
Ambion) and Snail cDNA plasmids (OriGene) were
transfected using Lipofectamine 2000 (Invitrogen) ac-
cording to the manufacturer’s protocol.
Real-time quantitative RT-PCR (qPCR)
Total RNA was extracted using TRIzol reagents (Invitrogen)
according to the manufacturer’s instructions. For mRNA
and miRNA analysis, cDNAs were synthesized using the
PrimeScript RT reagent kit (Takara). Then, qPCRs were
performed by using the Takara SYBR Premix Ex Taq II
(Takara) and the 7500 Real-Time PCR System (Applied
Biosystems). The primer sequences for Snail [12], E-
cadherin [12], ZO-1 [12], N-cadherin [12], Vimentin
[12], CD44 [13], CD133 [12] and GAPDH [12] have
been previously reported. For miRNA analysis, qPCRs
were performed using the NCode miRNA qRT-PCR
analysis (Invitrogen, CA, USA). Forward primer is the
exact sequence of the mature miR-137 and miR-34a.
The mRNA and miRNA expression data were normalized
to GAPDH and U6, respectively. Results were represented
as the fold change relative to respective controls.
Cell invasion assay
OC cells were grown to 50–70 % confluence and trans-
fected as indicated. After 24 h, cells were seeded into
upper chamber of Boyden chambers coated with Matri-
gel as described previously [14, 15]. After incubation
for 24 h, the non-invading cells were gently removed
with a cotton swab. Invasive cells located on the lower
surface of chamber were stained with Giemsa and
counted under a microscope. Relative cell invasion
activities were expressed as the fold change over res-
pective controls.
Sphere formation assay
Single cells (1000 cells per well) were plated onto a 24-
well ultra-low attachment plate (Corning) in serum-
free DMEM/F12 medium supplemented with N2 plus
media supplement (Invitrogen), 20 ng/ml epidermal
growth factor (Invitrogen), 20 ng/ml basic fibroblast
growth factor (Invitrogen) and 4 mg/ml heparin
(Sigma-Aldrich). After 10 days of culture, the number
of spheres larger than 50 μm was counted under an
inverted microscope.
Cell viability assay and cell apoptosis assay
Cell counting kit-8 assay (Dojindo) and Caspase-Glo 3/7
assay (Promega) were used to assess cell viability and cell
apoptosis as previously reported [16]. For the cell via-
bility assay, OC cells and NOEC cells were seeded were
seeded at a density of 5 × 103 per well in 96-well plates
for 24 h, and then transfected with 30 nM of miR-137 or
miR-34a mimic or negative control mimic (Neg mimic).
After 72 h, 10 μl of Cell counting kit-8 solution was added
into each well and the plates were incubated for additional
4 h at 37 °C. The UV absorbance of each sample was mea-
sured in a microplate reader at 450 nm. For the apoptotic
assay, caspase-3/7 activity was analyzed in accordance
with the manufacturer’s protocol. Briefly, OC and NOEC
cells were seeded into 96-well plates and transfected as
described above. After 72 h, an equal volume of Caspase-
Glo 3/7 reagent was added into each well, and the cells
were incubated at room temperature in the dark.
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Luminescence was measured after 3 h of incubation with
the caspase substrate.
Western blot analysis
Cells were harvested 24 h after transfections. Equal
amounts of protein lysates (30 μg) were separated by
10 % SDS-PAGE for immunoblots with antibodies to
Snail (Abcam), E-cadherin (GenScript), N-cadherin (BD
Biosciences), Vimentin (GenScript) and GAPDH (Santa
Cruz). Primary antibodies were used at a dilution of
1:1000. A horseradish peroxidase-conjugated anti-rabbit
or anti-mouse immunoglobulin-G antibody was used as
the secondary antibody (1:5000; Santa Cruz). Signals were
detected using enhanced chemiluminescence reagents
(Amersham Biosciences).
Dual luciferase reporter assay
The Snail 3′-UTR luciferase vector was purchased from
OriGene. Mutations in the miR-137 or miR-34a-binding
sequence were generated by using the QuickChange Mu-
tagenesis Kit (Stratagene). For luciferase assay, OC cells
were seeded onto 24-well plates and transfected after 24 h
with 100 ng of firefly luciferase reporter plasmid, 10 ng of
Renilla report plasmid as normalization control, together
with miR-137 or miR-34a mimic or Neg mimic. After 24 h,
a Dual Luciferase Reporter Assay (Promega) was per-
formed as previously reported [17]. The firefly luciferase
activity was normalized to the Renilla luciferase activity.
Clinical samples
Matched serous OC and corresponding adjacent normal
ovarian tissues were obtained from 50 patients undergoing
resection at the Department of Gynecology, State Key
Laboratory of Oncology in South China, Sun Yat-sen
University Cancer Center (Guangzhou, China). Tumor and
non-cancerous tissues were confirmed histologically by
Hematoxylin and Eosin staining. All samples were collected
from consenting individuals according to the protocols
approved by the Ethics Review Board at Sun Yat-sen Uni-
versity Cancer Center. All tissue samples were immediately
snap-frozen in liquid nitrogen. They were kept in a -80 °C
freezer and total RNA was isolated using TRIzol reagents.
Statistical analysis
Results are expressed as mean ± s.e.m. from at least
three independent experiments performed in triplicate.
2-tailed Student’s t-test was used for statistical analysis.
The log-rank test was used for survival analysis. The
value of P < 0.05 were considered as significant.
Fig. 1 MiR-137 and miR-34a are downregulated in OC tissues and decreased expressions of miR-137 and miR-34a are associated with poor survival in
OC patients. a Venn diagram showing the overlap of miRNAs that were predicted to bind to the Snail 3′-UTR by alternative algorithms (TargetScan,
miRSystem and DIANA-MicroT-CDS). The 6 predicted miRNAs were common to these three algorithms. b, c qPCR analysis of miR-137 (b) and miR-34a
(c) levels in 50 paired cancerous and normal tissue samples from OC patients. d, e Kaplan-Meier analysis of overall survival in 50 OC patients with high
median (n = 25) or low median (n = 25) expression levels of miR-137 (d) or miR-34a (e)
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Results
MiR-137 and miR-34a are downregulated in OC tissues
and OC cell lines, and decreased expression of miR-137
and miR-34a is associated with poor survival in OC patients
To investigate miRNA regulation of Snail, we first
employed multiple algorithms, including TargetScan,
miRSystem and DIANA-MicroT-CDS, to screen the
specific miRNAs that can target the 3′-untranslated re-
gion (3′-UTR) region of the Snail mRNA. These analyses
revealed six common miRNAs predicted to bind the 3′-
UTR of the Snail transcript (Fig. 1a). For example, target
prediction algorithms predicted one putative binding site
for miR-137 in the 3′-UTR of Snail (nt 444-450) and
recognized one binding site for miR-34a in Snail 3′-
UTR (nt 86–93) [10].
Next, we sought to determine whether their expression
is altered in human OC by measuring the expression
level of these 6 miRNAs in 50 pairs of human OC sam-
ples and adjacent normal ovarian tissues. Interestingly,
the levels of all 6 miRNAs were significantly decreased
in OC tissues compared with adjacent normal ovarian
tissues (data not shown). Among them, miR-137 and
miR-34a were the most significantly down-regulated
miRNAs (Fig. 1b and c), and selected to examine their
effects on Snail expression. To examine whether the
downregulation of miR-137 or miR-34a has any clinical
significance in OC, we analyzed the association between
miR-137 or miR-34a expression and patient prognosis.
OC patients population were divided into two groups
based on high (n = 25) or low (n = 25) expression of
miR-137 or miR-34a according to the median expression
levels among OC specimens, and Kaplan–Meier curves
for overall survival was plotted. Patients with lower miR-
137 or miR-34a expression had significantly shorter
overall survival (Fig. 1d and e). Consistent with these re-
sults, both miR-137 and miR-34a were clearly reduced
in two OC cell lines (SKOV-3 and ES-2) compared with
normal ovarian epithelial NOEC cells (Fig. 2a).
Snail is a direct target of miR-137 and miR-34a in OC cells
To determine whether Snail is a direct target of miR-137
and miR-34a, we transfected a human OC ES-2 cell line
(which expresses very high levels of endogenous Snail
and lacks the expression of miR-137 and miR-34a) with
pre-miRNA-137 or pre-miRNA-34a, together with a firefly
luciferase reporter vector containing the Snail 3′-UTR.
We found significant repression of luciferase activities by
either miR-137 or miR-34a (Fig. 2b and c). In addition,
these inhibitory effects of miR-137 or miR-34a on lucife-
rase activities were eliminated following mutations tar-
geting the predicted-binding sites of miR-137 or miR-34a
within the Snail 3′-UTR (Fig. 2b and c), demonstrating
that they bind directly to the 3′-UTR of Snail.
Fig. 2 Snail is a direct target of miR-137 and miR-34a in OC cells. a Relative miR-34a expression in OC cell lines (SKOV-3 and ES-2) and normal ovarian
epithelial NOEC cells. b, c ES-2 cells were transfected with reporter constructs containing either wild-type (WT) Snail, or Snail 3′-UTR with mutation (MUT),
along with miR-137 mimic (b), miR-34a mimic (c), or negative control mimic (Neg mimic), respectively. Relative luciferase activity was measured. d, e qPCR
analysis of Snail expression in OC cells after overexpression (d) or knockdown (e) of miR-137 and miR-34a. f Western blotting analysis of Snail expression in
OC cells after overexpression or knockdown of miR-137 and miR-34a. g, h qPCR analysis of indicated mRNAs in OC cells after transient overexpression or
knockdown of miR-137 (g) and miR-34a (h). i Relative mRNA expression of Snail in OC tissues and matched normal tissues. j Analysis of Snail mRNA
expression using microarray (Oncomine) on normal ovary versus OC tissue. **P< 0.01
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To directly assess if these miRNAs had a biological
effect on Snail, mRNA and protein expression of Snail
was examined in ES-2 and SKOV-3 cells following trans-
fection of miRNA mimics or inhibitors, respectively. As
expected, Snail mRNA and protein were down-regulated
in ES-2 cells transfected with miR-137 or miR-34a mimic
(Fig. 2d and f). In contrast, transfection with miR-137 or
miR-34a inhibitor into SKOV-3 cells (which has relatively
higher levels of miR-34a and miR-137) up-regulated Snail
expression at mRNA and protein levels (Fig. 2e and f).
Then we examined the expression of epithelial marker E-
cadherin, mesenchymal marker N-cadherin and Vimentin
in OC cells after the overexpression or knockdown of
miR-137 and miR-34a, using qPCR analysis. ES-2 cells
transfected with miR-137 or miR-34a mimic showed in-
creased levels of E-cadherin and decreased expression of
N-cadherin and Vimentin (Fig. 2g). However, transfection
of SKOV-3 cells with miR-137 or miR-34a inhibitor re-
versed these effects (Fig. 2h).
Next, we examined the correlation between the ex-
pression of miR-137, miR-34a and Snail mRNA expres-
sion. We found that Snail mRNA level was significantly
increased in OC samples compared with their non-
tumor counterparts (Fig. 2i). Next, we chose to com-
pare our data with existing published gene expression
database on OC. Importantly, our analysis of the TCGA
OC samples revealed significantly higher Snail tran-
script levels in OC samples, relative to normal ovaries
(Fig. 2j), supporting a negative correlation between miR-
137 or miR-34a and Snail expression in human OCs.
Collectively, these results suggest that both miR-137 and
miR-34a suppress Snail by targeting specific sites within
the 3′-UTR of Snail.
MiR-137 and miR-34a inhibit EMT, invasion and
sphere-forming ability of OC cells
We also examined the potential effects of miR-137 and
miR-34a on EMT features, invasive and sphere-forming
abilities of OC cells. For this, we transiently reduced or
overexpressed miR-137 and miR-34a in SKOV-3 and
ES-2 cells, which express relatively higher or lower ex-
pression of miR-137 and miR-34a, respectively (Fig. 2a).
The down-regulation of miR-137 or miR-34a in SKOV-3
cells induced a spindle-like mesenchymal morphology
(Fig. 3a), and the overexpression of miR-137 or miR-34a
in ES-2 cells resulted in an epithelial morphology change
(Fig. 3b). We further investigated the effects of knock-
down and overexpression of these two miRNAs on
EMT, OC cell invasion and sphere formation ability.
Matrigel invasion assay and sphere formation assay
Fig. 3 MiR-137 and miR-34a inhibit EMT, invasion and sphere-forming ability of OC cells. a, b Cellular morphology of OC cells after transient
knockdown (a) or overexpression (b) of miR-137 and miR-34a. Scale bar = 200 μm (a) and 100 μm (b). c, d Cell invasion (c) and sphere formation
(d) of OC cells after transient knockdown or overexpression of miR-137 and miR-34a. e, f qPCR analysis of indicated mRNAs in SKOV-3 (e) and
ES-2 (f) cells after transient knockdown or overexpression of miR-137 and miR-34a. g Representative images of invaded SKOV-3 cells after
transient transfection with miR-137 inhibitor or miR-34a inhibitor or negative control inhibitor (Neg inhibitor). h Representative images of
spheres formed from ES-2 cells transfected with miR-137 or miR-34a mimic or Neg mimic. Scale bar =100 μm. **P < 0.01
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demonstrated that knockdown of miR-137 or miR-34a
using antisense oligonucleotides in SKOV-3 cells sig-
nificantly promoted cell invasion and sphere formation,
whereas overexpression of miR-137 or miR-34a with
miRNA mimics in ES-2 cells inhibited these malignant
features (Fig. 3c and d). Then we examined the expression
of epithelial marker ZO-1 and cancer stemness markers
(CD44 and CD133) in OC cells after the knockdown and
overexpression of miR-137 and miR-34a, using qPCR as-
says. SKOV-3 cells transfected with miR-137 or miR-34a
inhibitor showed decreased levels of ZO-1 and increased
expression of CD44 and CD133 (Fig. 3e). However, trans-
fection of ES-2 cells with miR-137 or miR-34a mimic in-
creased the mRNA expression of ZO-1 and suppressed
that of CD44 and CD133 (Fig. 3f). These data suggest that
miR-137 and miR-34a inhibit mesenchymal characteristics
and reduces self-renewal properties of OC cells.
MiR-137 and miR-34a modulate EMT, invasion and
sphere-forming ability of OC cells through targeting Snail
To further corroborate the above observations, we inves-
tigated whether silencing of Snail with specific siRNA
could repress the miR-137 or miR-34a inhibitor-induced
OC cell invasion and sphere formation, or whether
transient over-expression of a Snail open reading frame
(ORF) could reverse the inhibitory effects of miR-137 or
miR-34a mimic on OC cell invasion and sphere forma-
tion. The miR-137 or miR-34a inhibitor-induced SKOV-3
cell invasion and sphere formation were significantly re-
duced by Snail siRNA (Fig. 4a and b). The overexpression
of Snail ORF in ES-2 cells partially rescued miR-137 or
miR-34a mimic-suppressed invasion and sphere formation
(Fig. 4a and b). Consistent with these data, inhibiting
Snail expression using siRNA in SKOV-3 cells trans-
fected with miR-137 or miR-34a inhibitor elevated the
expression of E-cadherin but reduced the expression of
N-cadherin and Vimentin (Fig. 4c). Moreover, rescuing
Snail expression with Snail ORF in the presence of
miR-137 or miR-34a mimic resulted in down-regulation
of E-cadherin and up-regulation of N-cadherin and
Vimentin (Fig. 4c). These data suggest that miR-137
and miR-34a inhibits invasive and stem cell-like proper-
ties of OC cells by suppressing Snail expression via its
3′-UTR.
Fig. 4 MiR-137 and miR-34a modulate EMT, invasion and sphere-forming ability of OC cells through targeting Snail. MiR-137 or miR-34a inhibitor
or Neg inhibitor was co-transfected into SKOV-3 cells, together with (or without) Snail siRNA. MiR-137 or miR-34a mimic or Neg mimic was
co-transfected into ES-2 cells, together with (or without) Snail cDNA vector lacking the 3′-UTR region. Cell invasion assay (a), sphere formation
assay (b) and Western blotting analysis of indicated proteins (c) in OC cells treated as described above were performed. **P < 0.01
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Overexpression of miR-137 and miR-34a decreases cell
viability and induces apoptosis in OC cells, without
significant cytotoxicity to normal NOEC cells
Next, we investigated if overexpressing miR-137 and
miR-34a could affect the viability and apoptosis of OC
cells and normal NOEC cells using cell viability and cell
apoptosis assays. The data demonstrated that the res-
toration of miR-137 and miR-34a expression in ES-2
and SKOV-3 cells led to a significant reduction in cell
viability and the induction of cell apoptosis, but had
no significant toxicity to NOEC cells (Fig. 5), indicating
the feasibility of inhibiting the growth of OC cells via the
therapeutic delivery of miR-137 or miR-34a mimics, with-
out causing significant toxicity to normal ovarian tissues.
Discussion
Despite advances in our understanding of the mecha-
nisms underlying Snail up-regulation, little is known
about the endogenous miRNA suppressors of Snail in
OC cells. We report in this study that in OC cells, both
miR-137 and miR-34a act as novel tumor repressors that
directly target Snail, which plays a pivotal role in con-
trolling the various cellular functions during cancer
metastasis, such as EMT, cell invasion, sphere-forming
ability and chemoresistance [18–23].
We show that miR-137 and miR-34a are downregu-
lated in OC samples, and we found a significant associ-
ation between decreased miR-137 or miR-34a expression
and worse patient prognosis. Furthermore, our in vitro
data have confirmed that reduced expression of miR-137
and miR-34a is critical for enhanced OC cell invasive-
ness and self-renewal, suggesting that these two miRNAs
can be potential therapeutic targets. Therefore, attenuating
the oncogenic functions of Snail by the use of miR-137 and
miR-34a could provide an exciting opportunity for the
development of therapy against OC.
Since a single mRNA might be targeted by multiple
miRNAs, we sought to newly identify crucial miRNAs
that reduce the expression of Snail in OC cells. We
demonstrate for the first time that miR-137 can directly
repress Snail expression through its binding to the spe-
cific binding site in the 3′-UTR of the human Snail
gene, thereby negatively regulating EMT, invasion and
self-renewal of OC cells. It is interesting to note that a
tumor-suppressive role for miR-137 has also been shown
in a variety of human tumors [24–26]. Thus, these data
and our current results reveal that, the anti-invasive
Fig. 5 Overexpression of miR-137 and miR-34a decreases cell viability and induces apoptosis in OC cells, without significant cytotoxicity to normal
NOEC cells. OC cells or normal NOEC cells were transfected with miR-137 mimic, miR-34a mimic or Neg mimic for 72 h, respectively. Cell viability
assay (a) and cell apoptosis assay (b) were performed. *P < 0.05. **P < 0.01. NS: Not Significant
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effects of miR-137 described here for OC—possibly me-
diated by Snail suppression—might be relevant in other
tumor types. Therefore, we postulate that replacing
tumor suppressive miR-137 targeting Snail might be a
promising approach for treating metastatic and recur-
rent OC.
As an important tumor suppressor, miR-34a controls
the expression of a host of target proteins involved in
cell proliferation, apoptosis, cancer stemness, metastasis
and chemoresistance [27], and it is often down-regulated
in numerous tumor types [28–32]. A previous study has
shown that miR-34a acts as a suppressor of Snail in
colon cancer [10], but to our knowledge, there are also
opposite findings showing its tumor-promoting roles in
other cancer type [33]. Whether miR-34a affects Snail
expression in OC cells have remained elusive. Here, we
have demonstrated that miR-34a is a direct inhibitor of
Snail in OC cells. Thus, the down-regulation of miR-34a
may be essential for Snail to induce EMT and OC
metastasis.
Our observation that upregulating tumor suppressive
miR-137 and miR-34a via miRNA mimics restored
tumor suppressor activity, with successful inhibition of
OC cell viability and invasiveness, provided a rationale
to investigate “miRNA replacement therapy for miR-137
and miR-34a”. However, there are concerns regarding
potential toxicity and off-target effects in normal tissues.
We showed here that the viability and apoptosis of nor-
mal NOEC cells was not altered after transfection with
miR-137 and miR-34a mimics, which display a high se-
lectivity for killing OC cells. These findings may be ex-
plained by several mechanisms [34]. Especially, large
differences in miR-137 and miR-34a levels between
normal NOEC cells and OC cells might account for the
tolerance of NOEC cells to these two miRNAs. The in
vivo anti-tumor efficacy and toxicity of miR-137 and
miR-34a warrants further investigation.
Conclusions
We identified a new mechanism whereby decreased ex-
pression of both miR-137 and miR-34a contributes to
enhanced Snail levels, which in turn promotes EMT, in-
vasion and sphere-forming of OC cells. Our results sug-
gest that these two miRNAs might become candidate
targets for the treatment of Snail-overexpressing OC.
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